Published on Aug 7, 2024 by Sara Chernikoff, USA TODAY
The demand for popular prescription drugs that treat diabetes, obesity and heart disease has skyrocketed over the past few years. New research from the University of Southern California showed a 442% increase in prescriptions for semaglutide between January 2021 and December 2023. Semaglutide is the active ingredient in diabetes drugs Ozempic, Rybelsus and Wegovy, a heart disease prevention and weight-loss drug.
Read more here